PubMed:23961597 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/23961597","sourcedb":"PubMed","sourceid":"23961597","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/23961597","text":"Canagliflozin: a new drug for type 2.\n","tracks":[{"project":"PCI_RCT","denotations":[{"id":"T1","span":{"begin":0,"end":13},"obj":"CI"},{"id":"T2","span":{"begin":30,"end":36},"obj":"DP"}],"attributes":[{"subj":"T1","pred":"source","obj":"PCI_RCT"},{"subj":"T2","pred":"source","obj":"PCI_RCT"}]},{"project":"Linmchun_800_3","denotations":[{"id":"T1","span":{"begin":0,"end":13},"obj":"CI"}],"attributes":[{"subj":"T1","pred":"source","obj":"Linmchun_800_3"}]},{"project":"luoyt2021_800_3","denotations":[{"id":"T1","span":{"begin":0,"end":13},"obj":"CI"}],"attributes":[{"subj":"T1","pred":"source","obj":"luoyt2021_800_3"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PCI_RCT","color":"#93dcec","default":true},{"id":"Linmchun_800_3","color":"#ece193"},{"id":"luoyt2021_800_3","color":"#c793ec"}]}]}}